Free Trial
Don't Let the A.I. Investing Revolution Pass You By!One More Chance - Get 30 Days Free

Insider Buying: The Biotech Growth Trust (LON:BIOG) Insider Buys 369 Shares of Stock

Written by MarketBeat
October 17, 2025
The Biotech Growth Trust logo with Financial Services background

Key Points

  • Julie Tankard, an insider at The Biotech Growth Trust PLC, purchased 369 shares at an average price of GBX 1,072, totaling approximately £3,955.68.
  • Following the insider buying, shares of The Biotech Growth Trust (LON:BIOG) rose by 1.9%, reaching GBX 1,100 during trading.
  • The Biotech Growth Trust focuses on capital appreciation through investments in the global biotechnology sector, aiming to outperform the NASDAQ Biotechnology Index.
  • Five stocks to consider instead of The Biotech Growth Trust.

The Biotech Growth Trust PLC (LON:BIOG - Get Free Report) insider Julie Tankard acquired 369 shares of The Biotech Growth Trust stock in a transaction dated Wednesday, October 15th. The stock was purchased at an average cost of GBX 1,072 per share, for a total transaction of £3,955.68.

The Biotech Growth Trust Trading Up 1.9%

Shares of LON:BIOG traded up GBX 20 during trading on Thursday, reaching GBX 1,100. The stock had a trading volume of 102,845 shares, compared to its average volume of 143,498. The stock has a market cap of £253.91 million, a price-to-earnings ratio of -419.37 and a beta of 0.50. The Biotech Growth Trust PLC has a 52 week low of GBX 612.70 and a 52 week high of GBX 1,105. The firm's fifty day moving average is GBX 939.09 and its 200 day moving average is GBX 806.69. The company has a debt-to-equity ratio of 11.02, a quick ratio of 0.00 and a current ratio of 0.59.

About The Biotech Growth Trust

(Get Free Report)

The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in The Biotech Growth Trust Right Now?

Before you consider The Biotech Growth Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Biotech Growth Trust wasn't on the list.

While The Biotech Growth Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover
10 Best Stocks to Own: Fall 2025

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.